載入...
Combinatorial approach to cancer immunotherapy: strength in numbers
Immune‐checkpoint blockade therapy with antibodies targeting CTLA‐4 and PD‐1 has revolutionized melanoma treatment by eliciting responses that can be remarkably durable and is now advancing to other malignancies. However, not all patients respond to immune‐checkpoint inhibitors. Extensive preclinica...
Na minha lista:
| 發表在: | J Leukoc Biol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608090/ https://ncbi.nlm.nih.gov/pubmed/27256570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5RI0116-013RR |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|